Literature DB >> 25283302

A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date.

Emilie Garnaes1, Katalin Kiss, Luise Andersen, Marianne H Therkildsen, Maria B Franzmann, Bettina Filtenborg-Barnkob, Estrid Hoegdall, Lene Krenk, Michael Josiassen, Christel B Lajer, Lena Specht, Kirsten Frederiksen, Lennart Friis-Hansen, Finn C Nielsen, Susanne K Kjaer, Bodil Norrild, Christian von Buchwald.   

Abstract

The aim was to explore whether the incidence of tonsillar squamous cell carcinomas (TSCCs) increased in Eastern Denmark, 2000-2010, and whether human papillomavirus (HPV) could explain the increase, and to assess the association of HPV prevalence with gender, age, and origin (i.e., the certainty of tonsillar tumor origin). We applied HPV DNA PCR and p16 immunohistochemistry to all TSCCs registered in the Danish Head and Neck Cancer Group (DAHANCA) and in the Danish Pathology Data Bank (n = 632). Pathologists reviewed and subdivided the tumors into two groups: specified and nonspecified TSCCs. Approximately 10% of HPV-positive tumors was genotyped by amplicon next-generation sequencing. The overall crude incidence of TSCCs increased significantly (2.7% per year) and was explained by an increasing incidence of HPV-positive TSCCs (4.9% per year). The overall HPV prevalence was 58%, with HPV16 being the predominant HPV type. In multivariate analysis, the HPV prevalence was associated with age (<55 vs. >60 years) (OR, 1.72; 95% CI 1.13-2.63) and origin (nonspecified vs. specified TSCCs) (OR, 0.15; 95% CI 0.11-0.22). The association of HPV prevalence with origin increased over time in specified TSCCs (OR per year, 1.10; 95% CI 1.01-1.19), whereas no change over time was observed among nonspecified TSCCs (OR per year, 0.99; 95% CI 0.90-1.08). In conclusion, the observed increase in the number of HPV-positive TSCCs can explain the increasing number of TSCCs in Eastern Denmark, 2000-2010. HPV prevalence was associated with younger age (<55 years) and a high certainty of tonsillar tumor origin.
© 2014 UICC.

Entities:  

Keywords:  HPV; oropharyngeal cancer; p16; tonsillar cancer

Mesh:

Year:  2014        PMID: 25283302     DOI: 10.1002/ijc.29254

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice.

Authors:  Haïtham Mirghani; Odile Casiraghi; Furrat Amen; Mingxiao He; Xiao-Jun Ma; Patrick Saulnier; Ludovic Lacroix; Françoise Drusch; Aïcha Ben Lakdhar; Jean Lacau Saint Guily; Cécile Badoual; Jean Yves Scoazec; Philippe Vielh
Journal:  Mod Pathol       Date:  2015-09-25       Impact factor: 7.842

2.  Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India.

Authors:  Abhishek Kumar Singh; Jitendra Kumar Kushwaha; Akshay Anand; Abhinav Arun Sonkar; Nuzhat Husain; Kirti Srivastava; Sudhir Singh
Journal:  Indian J Surg Oncol       Date:  2016-09-22

3.  Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.

Authors:  V C Sandulache; Y L Lei; L E Heasley; M Chang; C I Amos; E M Sturgis; E Graboyes; E Y Chiao; N Rogus-Pulia; J Lewis; A Madabhushi; M J Frederick; A Sabichi; M Ittmann; W G Yarbrough; C H Chung; R Ferrarotto; Weiyuan Mai; H D Skinner; U Duvvuri; P Gerngross; A G Sikora
Journal:  Oral Oncol       Date:  2019-10-22       Impact factor: 5.337

4.  Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.

Authors:  Guro Haugen Fossum; Agnes Kathrine Lie; Peter Jebsen; Lars Erik Sandlie; Jon Mork
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-20       Impact factor: 2.503

5.  Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.

Authors:  Niclas Rubek; Hani Ibrahim Channir; Birgitte Wittenborg Charabi; Christel Bræmer Lajer; Katalin Kiss; Hans Ulrik Nielsen; Jens Bentzen; Jeppe Friborg; Christian von Buchwald
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-01-03       Impact factor: 2.503

6.  Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method.

Authors:  Gypsyamber D'Souza; William H Westra; Steven J Wang; Annemieke van Zante; Alicia Wentz; Nicole Kluz; Eleni Rettig; William R Ryan; Patrick K Ha; Hyunseok Kang; Justin Bishop; Harry Quon; Ana P Kiess; Jeremy D Richmon; David W Eisele; Carole Fakhry
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777

7.  Exploring the implications of HPV infection for head and neck cancer.

Authors:  Nigel Field; Matt Lechner
Journal:  Sex Transm Infect       Date:  2015-04-21       Impact factor: 3.519

Review 8.  Human papillomavirus and tonsillar and base of tongue cancer.

Authors:  Torbjörn Ramqvist; Nathalie Grün; Tina Dalianis
Journal:  Viruses       Date:  2015-03-20       Impact factor: 5.048

9.  Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status.

Authors:  Malin Wendt; Lalle Hammarstedt-Nordenvall; Mark Zupancic; Signe Friesland; David Landin; Eva Munck-Wikland; Tina Dalianis; Anders Näsman; Linda Marklund
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

10.  Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations.

Authors:  Stefan Holzhauser; Nicole Wild; Mark Zupancic; Ramona G Ursu; Cinzia Bersani; Anders Näsman; Ourania N Kostopoulou; Tina Dalianis
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.